Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) whether deferred revenue expenditure and prepayment charges were allowable as business deductions; (ii) whether additional evidence could be admitted in transfer pricing proceedings and whether the arm's length price adjustment was sustainable; (iii) whether dividend received from the Sri Lankan subsidiary was taxable in India.
Issue (i): whether deferred revenue expenditure and prepayment charges were allowable as business deductions.
Analysis: The claims were examined on the footing that the expenditure was revenue in nature but spread over more than one year in accordance with the assessee's consistent accounting treatment. The earlier orders in the assessee's own case had accepted the same treatment, and the Tribunal followed that earlier view. The same approach was applied to the prepayment charges, which were also treated as amortisable business expenditure.
Conclusion: The deductions for deferred revenue expenditure and prepayment charges were rightly allowed, in favour of the assessee.
Issue (ii): whether additional evidence could be admitted in transfer pricing proceedings and whether the arm's length price adjustment was sustainable.
Analysis: The Tribunal held that the assessee was not estopped from producing further material before the appellate authority, especially when the evidence was sent to the TPO for comments and no objection was raised as to admissibility. On merits, the CUP method adopted by both sides was found inadequate because the comparables were not truly comparable, the data covered only limited transactions, and the monthly and yearly price bases were mismatched. The Tribunal also found that the profit split method lacked a proper FAR analysis. The alternative TNMM approach, based on the selected comparable pharmaceutical companies, was accepted because the comparables were functionally similar and the assessee's margin was not inferior to theirs.
Conclusion: The admission of additional evidence was proper and the transfer pricing addition was unsustainable, in favour of the assessee.
Issue (iii): whether dividend received from the Sri Lankan subsidiary was taxable in India.
Analysis: The Tribunal applied the treaty override principle under section 90(2) and followed the ratio that dividend income is taxable in the contracting state where it accrues. It accepted that the India-Sri Lanka treaty provisions on dividend taxation were materially similar to the India-Malaysia treaty considered in the cited Supreme Court ruling. It also accepted that the Sri Lankan subsidiary operated in a tax-exempt regime and that the relevant treaty provisions permitted relief accordingly.
Conclusion: The dividend received from the Sri Lankan subsidiary was not taxable in India, in favour of the assessee.
Final Conclusion: The Department's appeals failed on all substantial grounds, and the relief granted by the appellate authority was sustained in full.
Ratio Decidendi: Consistent accounting treatment supported by earlier acceptance, coupled with reliable appellate verification, can justify deferred revenue recognition; in transfer pricing, comparability must rest on truly comparable data and an appropriate method; and treaty provisions prevail over the Act for dividend taxation where the income accrues in the treaty partner state.